Multiway sleep-wake cycle regulator
NET 2401
NET 2401Àº ÇÑ¼Ó´Ü ¹× ¿øÁö ÃßÃâ¹°À» À¯È¿¼ººÐÀ¸·Î ÇÏ´Â ºÒ¸éÁõ °³¼±À» À§ÇÑ Æ¯Çã Á¶¼º¹°ÀÔ´Ï´Ù.
SCIE ³í¹® µîÀ» ÅëÇØ ¾Æµ¥³ë½Å ¼ö¿ëü ¹× ¼ö¸éÈ£¸£¸ó ¸á¶óÅä´Ñ Áõ°¡°¡ È®ÀεǾúÀ¸¸ç
ÀÔ¸é Àẹ±â °¨¼Ò, ¼ö¸é½Ã°£ Áõ°¡¿Í Àá¿¡¼ ±ú¾î³ ÈÄ È¸º¹ ½Ã°£À» °¨¼Ò½ÃÄÑ ¼ö¸é ½Ã°£ »Ó¸¸ ¾Æ´Ï¶ó ¼ö¸éÀÇ Áú±îÁö °³¼±ÇÕ´Ï´Ù.

Exclusivity
ƯÇã ¸íĪ: ºÒ¸éÁõ ¿¹¹æ ¶Ç´Â Ä¡·á¿ë Á¶¼º¹°
(Composition for Prevention or Treatment of Insomnia)
±¹°¡ | µî·Ï¹øÈ£ | ±¹°¡ | µî·Ï¹øÈ£ |
---|---|---|---|
´ëÇѹα¹ | 10-1106110 | À¯·´(µ¶ÀÏ, ÇÁ¶û½º, ¿µ±¹) | 2370072 |
¹Ì±¹ | 8,372,453 | ÀϺ» | 5456152 |
ij³ª´Ù | 2756742 | Áß±¹ | ZL201080013588.4 |
Mechanism of Action
¼ö¸é ¾Ð·ÂÀ» ÀÏÀ¸Å°´Â ¼ö¸é ¹°Áú, ¾Æµ¥³ë½Å ¼ö¿ëü ½ÅÈ£ Àü´Þ Á¶Àý
+ ¼ö¸éÈ£¸£¸ó ¸á¶óÅä´Ñ Áõ°¡
+ ¼ö¸éÈ£¸£¸ó ¸á¶óÅä´Ñ Áõ°¡
¾Æµ¥³ë½Å ¼ö¿ëü È°¼º ¹× ¸á¶óÅä´Ñ ³óµµ Áõ°¡

reference agonist N6-cyclopentyladenosine(CPA) ´ëºñ È°¼º(%) ¹ÝÀÀ
2ÁÖ°£ Åõ¿© in vivo test °á°ú


¼ö¸é ½Ã°£ ¹× ȸº¹ ½Ã°£ °³¼±
2ÁÖ°£ Åõ¿©, Pentobarbital ¼ö¸é À¯µµ in vivo test °á°ú

ÀáÀÌ µå´Â µ¥ °É¸®´Â ½Ã°£ 22% °¨¼Ò

ÀáÀÚ´Â ½Ã°£ 50% Áõ°¡

ȸº¹ ½Ã°£(Recovery time)19% °¨¼Ò Food Science and Biotechnology (2024)
Recommended dosage
960 ~ 1920 mg/day